Clinical trial
A Randomized, Unicenter, Parallel Study of the Effect of Dapagliflozin on Central Blood Pressure Reduction Compared to Glimepiride in Adult Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control.
NCT02919059 is registered in ClinicalTrials.gov with IInstituto Gallego de Medicina Vascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Unicenter, Parallel Study of the Effect of Dapagliflozin on Central Blood Pressure Reduction Compared to Glimepiride in Adult Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control.
- Lead sponsor
- IInstituto Gallego de Medicina Vascular
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 13, 2016
- Completion date
- August 31, 2019
- Enrollment
- 159 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.